Africa Health Research Institute NPC
Durban, Kwazulu-Natal, South Africa
Purpose
to develop new drugs to boost the effects of tuberculosis vaccination by performing a genetic screen, Tn-seq, to identify specific bacterial genes protecting the causative Mycobacterium tuberculosis from vaccine-mediated immune destruction
Division
Global Health
Date
June 2020
Region Served
GLOBAL
Committed amount
$200,000
Grant topic
Discovery and Translational Sciences
Duration (months)
52
Grantee location
Durban, Kwazulu-Natal, South Africa
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.